Jazz Pharmaceuticals: Truist Securities raises target price to $286 from $281
JAZZ•Truist Securities raised its target price for Jazz Pharmaceuticals to $286 from $281.
Related News
Google, Unity partner on AI-driven game creation platform Unity Spark
U•
Verastem Inc: B. Riley raises target price to $19 from $16
VSTM•
BYD will struggle to do a better Toyota impression
BYDDY•
Option Care Health: JP Morgan cuts to neutral from overweight
OPCH•
Neogenomics, Inc.: BofA Global Research raises price objective to $20 from $16
NEO•